Concr is an emerging predictive software platform built to combat cancer.
Concr combines cutting edge machine learning techniques with a deep scientific understanding of tumour progression to accurately predict cancer evolution in response to treatment.
This will enable clinicians to adapt treatments proactively, rather than reactively, to prevent treatment resistance and improve treatment efficacy through precision medicine.
Concr aims to:
• Reduce treatment resistance
• Cut the cost of cancer treatment
• Enable proactive treatment adaptation
• Save lives
Location: United Kingdom, England, Cambridge
Employees: 11-50
Total raised: $1.51M
Founded date: 2018
Investors 4
| Date | Name | Website |
| - | Syndicate ... | syndicater... |
| 16.08.2021 | Cambridge ... | cambridgea... |
| - | Parkwalk A... | parkwalkad... |
| - | IDEALondon | idealondon... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 31.03.2023 | Seed | $1.51M | Syndicate ... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 03.04.2024 | From generative chemistry to computational astrophysics, sta... | Here are a few startups in the cancer space that made headlines recently The recent revelation of Pr... | vator.tv/n... |
| 31.03.2023 | Cambridge investors swoop to Concr in £1.22m seed round | - | cambridgea... |